Four in 10 insured adults under age 64 said they received an unexpected medical bill in the past year, according to a poll by the Kaiser Family Foundation.
A common theme this earnings season: U.S. business executives are ready to relocate their supply chains if the cost of importing Chinese goods becomes prohibitive.
As a shortage of epinephrine pens continues to grip the U.K., authorities have agreed to extend the expiration date on a second injector to help ease the situation.
If the U.K. leaves the EU with no deal, it could be “catastrophic” for medicine supplies — and necessitate emergency powers, the pharmaceuticals industry says.
As pharmaceutical companies have faced more heat for their pricing practices, they’ve found someone else to blame: “middlemen” who extract discounts from drugmakers.